Mycophenolate mofetil, azathioprine and tacrolimus: mechanisms in rheumatology von Broen, Jasper C. A., van Laar, Jacob M.

Volltext

T cells in systemic sclerosis: a reappraisal von O'REILLY, Steven, HÜGLE, Thomas, LAAR, Jacob M. Van

Volltext

Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis von Eurelings, Laura E M, Miedema, Jelle R, Dalm, Virgil A S H, van Daele, Paul L A, van Hagen, P Martin, van Laar, Jan A M, Dik, Willem A

Volltext

Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial von Khanna, Dinesh, Prof, Denton, Christopher P, Prof, Jahreis, Angelika, MD, van Laar, Jacob M, Prof, Frech, Tracy M, MD, Anderson, Marina E, FRCP, Baron, Murray, MD, Chung, Lorinda, MD, Fierlbeck, Gerhard, MD, Lakshminarayanan, Santhanam, MD, Allanore, Yannick, Prof, Pope, Janet E, MD, Riemekasten, Gabriela, Prof, Steen, Virginia, Prof, Müller-Ladner, Ulf, Prof, Lafyatis, Robert, MD, Stifano, Giuseppina, MD, Spotswood, Helen, PhD, Chen-Harris, Haiyin, PhD, Dziadek, Sebastian, PhD, Morimoto, Alyssa, PhD, Sornasse, Thierry, PhD, Siegel, Jeffrey, MD, Furst, Daniel E, Prof

Volltext

Patient-centred care in established rheumatoid arthritis von Voshaar, M.J.H., MSc, Nota, I., MSc, van de Laar, M.A.F.J., MD, PhD, van den Bemt, B.J.F., PharmD, PhD

Volltext

Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoart... von Tubach, F., Ravaud, P., Martin‐Mola, E., Awada, H., Bellamy, N., Bombardier, C., Felson, D. T., Hajjaj‐Hassouni, N., Hochberg, M., Logeart, I., Matucci‐Cerinic, M., van de Laar, M., van der Heijde, D., Dougados, M.

Volltext

Recommendations for the management of hemophagocytic lymphohistiocytosis in adults von La Rosée, Paul, Horne, AnnaCarin, Hines, Melissa, von Bahr Greenwood, Tatiana, Machowicz, Rafal, Berliner, Nancy, Birndt, Sebastian, Gil-Herrera, Juana, Girschikofsky, Michael, Jordan, Michael B., Kumar, Ashish, van Laar, Jan A.M., Lachmann, Gunnar, Nichols, Kim E., Ramanan, Athimalaipet V., Wang, Yini, Wang, Zhao, Janka, Gritta, Henter, Jan-Inge

Volltext

The clinical utility of bone marker measurements in osteoporosis von Wheater, Gillian, Elshahaly, Mohsen, Tuck, Stephen P, Datta, Harish K, van Laar, Jacob M

Volltext

European reference network for rare vascular diseases (VASCERN) consensus statement for the screening and management of patients with pathogenic ACTA2 variants von van de Laar, Ingrid M B H, Arbustini, Eloisa, Loeys, Bart, Björck, Erik, Murphy, Lise, Groenink, Maarten, Kempers, Marlies, Timmermans, Janneke, Roos-Hesselink, Jolien, Benke, Kalman, Pepe, Guglielmina, Mulder, Barbara, Szabolcs, Zoltan, Teixidó-Turà, Gisela, Robert, Leema, Emmanuel, Yaso, Evangelista, Arturo, Pini, Alessandro, von Kodolitsch, Yskert, Jondeau, Guillaume, De Backer, Julie

Volltext

MiR-29a reduces TIMP-1 production by dermal fibroblasts via targeting TGF-β activated kinase 1 binding protein 1, implications for systemic sclerosis von Ciechomska, Marzena, O'Reilly, Steven, Suwara, Monika, Bogunia-Kubik, Katarzyna, van Laar, Jacob M

Volltext

A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300–600 mg/day versus benzbromarone 100–200 mg/day in patients with gout von Reinders, M K, Haagsma, C, Jansen, T L Th A, van Roon, E N, Delsing, J, van de Laar, M A F J, Brouwers, J R B J

Volltext

Participation in online patient support groups endorses patients’ empowerment von van Uden-Kraan, C.F, Drossaert, C.H.C, Taal, E, Seydel, E.R, van de Laar, M.A.F.J

Volltext

Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation von Snowden, J A, Saccardi, R, Allez, M, Ardizzone, S, Arnold, R, Cervera, R, Denton, C, Hawkey, C, Labopin, M, Mancardi, G, Martin, R, Moore, J J, Passweg, J, Peters, C, Rabusin, M, Rovira, M, van Laar, J M, Farge, D

Volltext

Healthcare professionals' perceptions on barriers and facilitators to DMARD use in rheumatoid arthritis von Voshaar, M J H, van den Bemt, B J F, van de Laar, M A F J, van Dulmen, A M, Vriezekolk, J E

Volltext

Determinants of Perceived Health Nonimprovement in Early Rheumatoid Arthritis Patients With Favorable Treatment Outcomes von Steunebrink, L. M. M., Oude Voshaar, M. A. H., Taal, E., Vonkeman, H. E., Zijlstra, T. R., Laar, M. A. F. J.

Volltext

Long-term disease and patient-reported outcomes of a continuous treat-to-target approach in patients with early rheumatoid arthritis in daily clinical practice von Versteeg, G. A., Steunebrink, L. M. M., Vonkeman, H. E., ten Klooster, P. M., van der Bijl, A. E., van de Laar, M. A. F. J.

Volltext

Sustained Beneficial Effects of a Protocolized Treat‐to‐Target Strategy in Very Early Rheumatoid Arthritis: Three‐Year Results of the Dutch Rheumatoid Arthritis Monitoring Remissio... von Vermeer, M., Kuper, H. H., Moens, H. J. Bernelot, Drossaers‐Bakker, K. W., Bijl, A. E., Riel, P. L. C. M., Laar, M. A. F. J.

Volltext

The diagnostic performance of dual energy CT for diagnosing gout: a systematic literature review and meta-analysis von Gamala, Mihaela, Jacobs, Johannes W G, van Laar, Jaap M

Volltext

Surveillance and epidemiology of hepatitis B and C in Europe - a review von Rantala, Merja, van de Laar, M J W

Volltext

Genome-wide association study in an admixed case series reveals IL12A as a new candidate in Behçet disease von Kappen, Jasper H, Medina-Gomez, Carolina, van Hagen, P Martin, Stolk, Lisette, Estrada, Karol, Rivadeneira, Fernando, Uitterlinden, Andre G, Stanford, Miles R, Ben-Chetrit, Eldat, Wallace, Graham R, Soylu, Merih, van Laar, Jan A M

Volltext